Jun-xi Lu

Shanghai Key Laboratory Of Diabetes Mellitus, Shanghai Key Clinical Center For Metabolic Disease
Shanghai, 200233, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

The Burden of Multiple Metabolic Diseases and Their Impact on Cardiovascular and Kidney Complications in Type 2 Diabetes: A 10-Year Real-World Study.

The Burden of Multiple Metabolic Diseases and Their Impact on Cardiovascular and Kidney Complications in Type 2 Diabetes: A 10-Year Real-World Study.

Journal: Diabetes, metabolic syndrome and obesity : targets and therapy

Published: June 30, 2025

Serum Magnesium Levels Are Negatively Associated with Obesity and Abdominal Obesity in Type 2 Diabetes Mellitus: A Real-World Study.

Serum Magnesium Levels Are Negatively Associated with Obesity and Abdominal Obesity in Type 2 Diabetes Mellitus: A Real-World Study.

Journal: Diabetes & metabolism journal

Published: November 08, 2023

High-normal serum bilirubin is a useful indicator to assess the risk of diabetic retinopathy in type 2 diabetes: A real-world study.

High-normal serum bilirubin is a useful indicator to assess the risk of diabetic retinopathy in type 2 diabetes: A real-world study.

Journal: Heliyon

Published: October 23, 2023

Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes.

Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes.

Journal: Diabetes, metabolic syndrome and obesity : targets and therapy

Published: September 21, 2022

High-normal unconjugated bilirubin is associated with decreased risk of chronic kidney disease in type 2 diabetes: A real-world study.

High-normal unconjugated bilirubin is associated with decreased risk of chronic kidney disease in type 2 diabetes: A real-world study.

Journal: Diabetes/metabolism research and reviews

Published: September 17, 2022

GA/HbA1c ratio is a simple and practical indicator to evaluate the risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: an observational study.

GA/HbA1c ratio is a simple and practical indicator to evaluate the risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: an observational study.

Journal: Diabetology & metabolic syndrome

Published: July 05, 2022

Waist-to-height ratio is a simple and practical alternative to waist circumference to diagnose metabolic syndrome in type 2 diabetes.

Waist-to-height ratio is a simple and practical alternative to waist circumference to diagnose metabolic syndrome in type 2 diabetes.

Journal: Frontiers in nutrition

Published: July 04, 2022

Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study.

Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study.

Journal: Frontiers in endocrinology

Published: May 12, 2022

Chaetocin attenuates atherosclerosis progression and inhibits vascular smooth muscle cell phenotype switching.

Chaetocin attenuates atherosclerosis progression and inhibits vascular smooth muscle cell phenotype switching.

Journal: Journal of cardiovascular translational research

Published: October 09, 2021

Albuminuria but not low eGFR is closely associated with atherosclerosis in patients with type 2 diabetes: an observational study.

Albuminuria but not low eGFR is closely associated with atherosclerosis in patients with type 2 diabetes: an observational study.

Journal: Diabetology & metabolic syndrome

Published: July 16, 2021

Waist-to-height ratio has a stronger association with cardiovascular risks than waist circumference, waist-hip ratio and body mass index in type 2 diabetes.

Waist-to-height ratio has a stronger association with cardiovascular risks than waist circumference, waist-hip ratio and body mass index in type 2 diabetes.

Journal: Diabetes research and clinical practice

Published: July 14, 2021

Deletion of Fam172a accelerates advanced atherosclerosis and induces plaque instability.

Deletion of Fam172a accelerates advanced atherosclerosis and induces plaque instability.

Journal: Atherosclerosis

Published: October 21, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026